Search Within

Anita Kumar

Formats
  1. Meeting Abstract (112)
  2. Journal Article (64)
  3. Review (8)
  4. Book Section (6)
  5. Research Letter (5)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (197)
  2. Department of Medicine (197)
  3. Hematologic Malignancies, Division of (197)
  4. Lymphoma (197)
  5. Survivorship Research (104)
  6. Population Sciences Research Program (103)

More Groups

People
  1. Andrew Zelenetz (136)
  2. Paul Hamlin (107)
  3. Alison Moskowitz (105)
  4. Ariela Noy (105)
  5. Maria Palomba (100)
  6. Steven Horwitz (98)

More People

Years
  1. 2025 (7)
  2. 2024 (33)
  3. 2023 (32)
  4. 2022 (12)
  5. 2021 (24)
  6. 2020 (17)

More Years

Publications
  1. Blood (84)
  2. Hematological Oncology (19)
  3. Journal of Clinical Oncology (13)
  4. Blood Advances (11)
  5. Haematologica (9)
  6. Leukemia and Lymphoma (8)

More Publications

Publishers
  1. American Society of Hematology (96)
  2. Wiley Blackwell (19)
  3. American Society of Clinical Oncology (13)
  4. Nature Publishing Group (10)
  5. Ferrata Storti Foundation (9)
  6. Taylor & Francis Group (9)

More Publishers

Results (197)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response to mosunetuzumab in patients with B-cell lymphomas relapsed or refractory after CAR-T cell therapy is associated with changes in lymphocyte counts
    Meeting Abstract

    Chong, E. A.; Penuel, E.; Bartlett, N. L.; Bosch, F.; Budde, L. E.; Fay, K.; Flinn, I. W.; Goy, A.; Kumar, A.; Lundberg, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes in mantle cell lymphoma with central nervous system involvement - A dual center study
    Meeting Abstract

    McLaughlin, N.; Joseph, A.; Wang, Y. C.; Pederson, L. D.; Geyer, S. M.; Witzig, T. E.; Zelenetz, A. D.; Villasboas, J. C. C.; Scordo, M.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A multicenter phase 2 trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in patients with treatment-naïve, TP53-mutant mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chabowska, M.; Devlin, M.; Dogan, A.; Falchi, L.; Garcia, R. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Subcutaneous (SC) mosunetuzumab (mosun) as first-line therapy for patients (pts) with high tumor-burden follicular lymphoma (FL): First results of a multicenter phase 2 study
    Meeting Abstract

    Falchi, L.; Okwali, M.; Ghione, P.; Owens, C.; Hamlin, P. A.; Lue, J. K.; Epstein-Peterson, Z. D.; Palomba, M. L.; Kumar, A.; Torka, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Predicting toxicities in older adults with non-Hodgkin lymphoma (NHL) receiving systemic chemotherapy: A prospective geriatric assessment (GA) study
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Ruxolitinib promotes clinical responses in large granular lymphocytic leukemia via suppression of JAK/STAT-dependent inflammatory cascades
    Meeting Abstract

    Moskowitz, A.; Rahman, J.; Ganesan, N.; Hannigan, K.; Ksanznak, K.; Bitton, H.; Lin, Y. H.; Davey, T.; Hancock, H.; Perez, L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Cassanello, G.; Rivas-Delgado, A.; Luna De Abia, A.; Corona, M.; Luttwak, E.; Okwali, M.; Isgor, I.; Galera, P.; Boardman, A. P.; Caron, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement
    Journal Article

    Ryan, C. E.; Zon, R. L.; Redd, R.; Fisher, D. C.; Shouval, R.; Kumar, A.; Crombie, J. L.; Sadrzadeh, H.; Kim, A. I.; Nayak, L.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Pirtobrutinib efficacy in covalent BTK-inhibitor pre-treated relapsed/refractory mantle cell lymphoma: Extended follow-up from BRUIN
    Meeting Abstract

    Lewis, D. J.; Wang, M. L.; Shah, N. N.; Jurczak, W.; Zinzani, P. L.; Eyre, T. A.; Cheah, C. Y.; Ujjani, C. S.; Koh, Y.; Izutzu, K.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save